{"zip": "519090", "sector": "Healthcare", "fullTimeEmployees": 8250, "longBusinessSummary": "Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the People's Republic of China. Its products include Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo, and for the patients of lung cancer and stomach cancer. The company also offers active pharmaceutical ingredients (APIs) and intermediates, such as diagnostic kit for IgM/IgG antibody to coronavirus; and diagnostic reagents and equipment, including diagnostic kit for human immunodeficiency virus antibody, diagnostic kit for anti-nuclear antibody panel, and diagnostic kit for tuberculosis specific infected T cells. In addition, it provides biologic products, traditional Chinese drug medicine, biochemical drugs, microbiological preparations, antibiotics, and pharmaceutical raw materials. The company also exports its products. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.", "city": "Zhuhai", "phone": "86 75 6813 5888", "country": "China", "companyOfficers": [], "website": "http://www.livzon.com.cn", "maxAge": 1, "address1": "Headquarters Building", "industry": "Drug Manufacturers\u2014Specialty & Generic", "address2": "38 Chuangye North Road Jinwan District", "ebitdaMargins": 0.19855, "profitMargins": 0.15201999, "grossMargins": 0.64405996, "operatingCashflow": 1962094720, "revenueGrowth": 0.114, "operatingMargins": 0.16483, "ebitda": 2315200512, "targetLowPrice": null, "recommendationKey": "none", "grossProfits": 6776621805, "freeCashflow": 592448960, "targetMedianPrice": null, "currentPrice": 25.4, "earningsGrowth": -0.096, "currentRatio": 2.198, "returnOnAssets": 0.06271, "numberOfAnalystOpinions": null, "targetMeanPrice": null, "debtToEquity": 17.969, "returnOnEquity": 0.1524, "targetHighPrice": null, "totalCash": 8825405440, "totalDebt": 2417493760, "totalRevenue": 11660702720, "totalCashPerShare": 9.431, "financialCurrency": "CNY", "revenuePerShare": 12.462, "quickRatio": 1.913, "recommendationMean": null, "exchange": "HKG", "shortName": "LIVZON PHARMA", "longName": "Livzon Pharmaceutical Group Inc.", "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "isEsgPopulated": false, "gmtOffSetMilliseconds": "28800000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "1513.HK", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_5567081", "uuid": "3532ed20-ea79-3bbf-8437-ded3ab1eff26", "market": "hk_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 1.934, "beta3Year": null, "enterpriseToEbitda": 9.743, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": 1.93, "revenueQuarterlyGrowth": null, "sharesOutstanding": 313236000, "fundInceptionDate": null, "annualReportExpenseRatio": null, "totalAssets": null, "bookValue": 13.425, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1609372800, "heldPercentInstitutions": 0.11868, "netIncomeToCommon": 1772642688, "trailingEps": null, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 1.8919924, "heldPercentInsiders": 0.52154, "nextFiscalYearEnd": 1672444800, "yield": null, "mostRecentQuarter": 1625011200, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 507244192, "beta": 0.611036, "enterpriseValue": 22555844608, "priceHint": 3, "threeYearAverageReturn": null, "lastSplitDate": 1562112000, "lastSplitFactor": "13:10", "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": -0.103, "priceToSalesTrailing12Months": 2.9076018, "dateShortInterest": null, "pegRatio": null, "ytdReturn": null, "forwardPE": 13.160622, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "previousClose": 25.65, "regularMarketOpen": 26, "twoHundredDayAverage": 32.416187, "trailingAnnualDividendYield": 0.048732944, "payoutRatio": 0.65029997, "volume24Hr": null, "regularMarketDayHigh": 26, "navPrice": null, "averageDailyVolume10Day": 794276, "regularMarketPreviousClose": 25.65, "fiftyDayAverage": 27.836765, "trailingAnnualDividendRate": 1.25, "open": 26, "averageVolume10days": 794276, "expireDate": null, "algorithm": null, "dividendRate": 1.51, "exDividendDate": 1622505600, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 25.1, "currency": "HKD", "regularMarketVolume": 523800, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 33904680960, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 616376, "dayLow": 25.1, "ask": 25.55, "askSize": 0, "volume": 523800, "fiftyTwoWeekHigh": 42, "fromCurrency": null, "fiveYearAvgDividendYield": 3.61, "fiftyTwoWeekLow": 25.1, "bid": 25.4, "tradeable": false, "dividendYield": 0.0496, "bidSize": 0, "dayHigh": 26, "regularMarketPrice": 25.4, "preMarketPrice": null, "logo_url": "https://logo.clearbit.com/livzon.com.cn"}